Interviews

Dr. Daniel Vitt

Immunic Therapeutics is a biotechnology company focused on developing innovative, small-molecule therapies for chronic inflammatory and autoimmune diseases, including multiple sclerosis and gastrointestinal disorders.

Kevin Hykes

CVRx is a commercial-stage medical device company that develops, manufactures, and commercializes neuromodulation solutions for cardiovascular diseases, notably its Barostim device for heart failure patients.

Matt Gline

Roivant Sciences is a multinational healthcare company that builds subsidiary life sciences and health technology companies. 

Bruce Andrews

Razat Gaurav

The world spends over $3 trillion annually on digitalization, but approximately 40 percent of that is wasted due to misalignment between business and technology teams, as well as disconnects between leadership and frontline employees. Planview's platform addresses these issues by bridging the gap between strategy and execution, reducing waste, and maximizing productivity.

Martin Tolar

Alzheon is a clinical-stage biopharmaceutical company developing oral treatments for Alzheimer's disease and other neurological disorders. The company recently completed a Phase 3 trial in patients with early stages of Alzheimer’s disease with its lead candidate ALZ-801/valiltramiprosate that targets neurotoxic amyloid oligomers. 

Nolan Townsend

Lexeo Therapeutics is a New York City-based clinical-stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.

Jim Gunton

New Jersey-headquartered Tech Council Ventures is a venture capital firm investing in early-stage enterprise and health technology companies in the U.S. 

Ivana Magovčević-Liebisch

Vigil Neuroscience is a biotechnology company focused on developing precision-based therapies targeting microglia dysfunction to treat rare and common neurodegenerative diseases.

Marshall Fordyce

Vera Therapeutics is a clinical-stage biotechnology company focused on developing treatments for serious immunological diseases.